| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2017-08-01 02:12:29 UTC |
|---|
| Update Date | 2022-09-22 18:34:30 UTC |
|---|
| HMDB ID | HMDB0094651 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Pyroglutamylvaline |
|---|
| Description | Pyroglutamylvaline, also known as pyro-glu-val or 5-oxoprolylvaline, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Based on a literature review very few articles have been published on Pyroglutamylvaline. |
|---|
| Structure | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(O)=O InChI=1S/C10H16N2O4/c1-5(2)8(10(15)16)12-9(14)6-3-4-7(13)11-6/h5-6,8H,3-4H2,1-2H3,(H,11,13)(H,12,14)(H,15,16)/t6-,8-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 5-Oxoprolylvaline | ChEBI | | L-Pyroglutamyl-L-valine | ChEBI | | p-Glu-val | ChEBI | | Pyro-glu-val | ChEBI | | Pyroglutamyl valine | ChEBI | | N-(5-oxo-L-Prolyl)-L-valine | HMDB | | N-(5-oxo-L-Prolyl)-valine | HMDB | | 5-oxo-L-Prolyl-L-valine | HMDB | | L-Pyrrolidonecarboxyl-L-valine | HMDB | | Pyrrolidin-2-one-5-carbonylvaline | HMDB | | Pyroglutamylvaline | HMDB |
|
|---|
| Chemical Formula | C10H16N2O4 |
|---|
| Average Molecular Weight | 228.248 |
|---|
| Monoisotopic Molecular Weight | 228.111007003 |
|---|
| IUPAC Name | (2S)-3-methyl-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}butanoic acid |
|---|
| Traditional Name | (2S)-3-methyl-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}butanoic acid |
|---|
| CAS Registry Number | 21282-10-0 |
|---|
| SMILES | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C10H16N2O4/c1-5(2)8(10(15)16)12-9(14)6-3-4-7(13)11-6/h5-6,8H,3-4H2,1-2H3,(H,11,13)(H,12,14)(H,15,16)/t6-,8-/m0/s1 |
|---|
| InChI Key | DTSWLLBBGHRXQH-XPUUQOCRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Valine or derivatives
- Proline or derivatives
- N-acyl-alpha-amino acid
- N-acyl-l-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Pyrrolidine carboxylic acid or derivatives
- Pyrrolidine-2-carboxamide
- Branched fatty acid
- Heterocyclic fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Fatty acid
- Pyrrolidone
- 2-pyrrolidone
- Pyrrolidine
- Secondary carboxylic acid amide
- Carboxamide group
- Lactam
- Organoheterocyclic compound
- Carboxylic acid
- Azacycle
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Organic oxygen compound
- Organopnictogen compound
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.32 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9247 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.23 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1424.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 227.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 94.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 153.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 60.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 263.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 342.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 115.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 671.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 302.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 992.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 198.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 217.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 349.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 231.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 129.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Pyroglutamylvaline,1TMS,isomer #1 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)O[Si](C)(C)C | 2019.7 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,1TMS,isomer #2 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C | 1966.5 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,1TMS,isomer #3 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)C(=O)O | 1963.6 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C | 2008.6 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C | 2006.9 | Standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C | 3048.4 | Standard polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1980.0 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2017.9 | Standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2785.2 | Standard polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1895.7 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2016.5 | Standard non polar | 33892256 | | Pyroglutamylvaline,2TMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2665.4 | Standard polar | 33892256 | | Pyroglutamylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 1960.5 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2097.4 | Standard non polar | 33892256 | | Pyroglutamylvaline,3TMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2352.6 | Standard polar | 33892256 | | Pyroglutamylvaline,1TBDMS,isomer #1 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)O[Si](C)(C)C(C)(C)C | 2246.6 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,1TBDMS,isomer #2 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 2216.2 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,1TBDMS,isomer #3 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)C(=O)O | 2198.0 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 2452.1 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 2422.6 | Standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 3031.4 | Standard polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2434.7 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2444.4 | Standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #2 | CC(C)[C@H](NC(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2816.0 | Standard polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2382.2 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2425.5 | Standard non polar | 33892256 | | Pyroglutamylvaline,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)O)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2755.2 | Standard polar | 33892256 | | Pyroglutamylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2640.3 | Semi standard non polar | 33892256 | | Pyroglutamylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2678.9 | Standard non polar | 33892256 | | Pyroglutamylvaline,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H]1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2683.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Pyroglutamylvaline GC-MS (Non-derivatized) - 70eV, Positive | splash10-001l-9200000000-9db84667672f6a505f45 | 2017-09-14 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Pyroglutamylvaline GC-MS (3 TMS) - 70eV, Positive | splash10-0a6r-6932300000-013d4bddc38160ccb236 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Pyroglutamylvaline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 10V, Negative-QTOF | splash10-0059-0490000000-c6f69f147e19e6d90c77 | 2017-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 20V, Negative-QTOF | splash10-07yi-3950000000-bce5cc05c920b36b4fdc | 2017-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 40V, Negative-QTOF | splash10-00kf-9200000000-add672a776175abea58c | 2017-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 10V, Positive-QTOF | splash10-02cr-3690000000-3bd2cf60b4176dafefff | 2017-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 20V, Positive-QTOF | splash10-0089-9300000000-e0b20d2fcc43e6cb45e5 | 2017-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 40V, Positive-QTOF | splash10-05gi-9100000000-987567c667aa950bbc60 | 2017-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 10V, Positive-QTOF | splash10-03gi-4980000000-ca77ede8584ae5157107 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 20V, Positive-QTOF | splash10-001i-9100000000-9b083dd619db45b224bd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 40V, Positive-QTOF | splash10-001i-9300000000-bc014979775b6ec4a63e | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 10V, Negative-QTOF | splash10-004i-0090000000-c8a3f11499151a4d3a87 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 20V, Negative-QTOF | splash10-004i-6900000000-fd52a1fe405d3f84c962 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyroglutamylvaline 40V, Negative-QTOF | splash10-0006-9100000000-544465ead7a4ca8f9b9b | 2021-09-22 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|